270
Emre Menteşe et al.
2-[2-(2-Methylbenzyl)-5(6)-nitro-1H-benzimidazol-1-yl]acetohydrazide (4a). m.p.: 250-252 °C,
IR (KBr): 3298 (NH,NH2), 3049 (Ar-H), 1656 (C=O), 1610 (C=N), 1513, 1315 (NO2) cm-1. 1H-
NMR (200 MHz, DMSO-d6) δ: 9.65 (s, 1H, NH), 8.44 (s, 1H, Ar-H), 8.25 (d, 1H, J = 8.1 Hz,
Ar-H), 8.13 (d, 1H, J = 8.1, Ar-H), 7.83-7.19 (m, 4H, Ar-H), 4.92 (2H, s, N-CH2), 4.36 (2H,s,
NH2), 4.17 (2H, q, J = 7.2, CH2), 2.27 (3H, t, J = 7.2, CH3). 13C-NMR (50 MHz, DMSO-d6) δ:
165.3 (C=O), 158.1 (C=N), 149.1 (C), 144.2 (C), 142.6 (C), 137.3 (C), 135.4, 133.7 (CH),
129.2 (CH), 127.7 (CH), 126.9 (CH), 122.9 (CH), 120.1 (CH), 118.5 (CH), 50.2 (CH2), 35.3
(CH2), 19.5 (CH3). ESI-MS m/z (rel. int.) 340 [M+1] (100), 305 (26), 267 (52), 235 (34). Anal.
C 60.17%, H 5.05%, N 20.64 %, calcd. for C17H17N5O3, C 60.13%, H 5.05%, N 20.65 %.
2-[2-(3-Methylbenzyl)-5(6)-nitro-1H-benzimidazol-1-yl]acetohydrazide (4b). m.p.: 255-256 °C,
IR (KBr): 3299 (NH, NH2), 3032 (Ar-H), 1654 (C=O), 1619 (C=N), 1510, 1312 (NO2) cm-1. 1H-
NMR (200 MHz, DMSO-d6) δ: 9.75 (s, 1H, NH), 8.52 (s, 1H, Ar-H), 8.31 (d, 1H, J = 8.0 Hz,
Ar-H,), 8.18 (d, 1H, J = 8.0, Ar-H), 7.91-7.23 (m, 4H, Ar-H), 4.89 (2H, s, N-CH2), 4.32 (2H,s,
NH2), 4.14 (2H, s, CH2), 2.27 (3H, s, CH3). 13C-NMR (50 MHz, DMSO-d6) δ: 167.1 (C=O),
159.2 (C=N), 150.3 (C), 146.3 (C), 144.7 (C), 139.2 (C), 137.3, 133.5 (CH), 129.1 (CH), 125.3
(CH), 122.4 (CH), 121.4 (CH), 120.4 (CH), 117.3 (CH), 48.2 (CH2), 33.3 (CH2), 17.9 (CH3).
ESI-MS m/z (rel. int.) 340 [M+1] (100), 305 (29), 267 (57), 235 (63). Anal. C 60.17%, H
5.05%, N 20.64 %, calcd. for C17H17N5O3, C 60.15%, H 5.02%, N 20.67 %.
2-[2-(2-Chlorobenzyl)-5(6)-nitro-1H-benzimidazol-1-yl]acetohydrazide (4c). m.p.: 245-246 °C,
IR (KBr): 3309 (NH, NH2), 3012 (Ar-H), 1657 (C=O), 1617 (C=N), 1511, 1310 (NO2) cm-1. 1H-
NMR (200 MHz, DMSO-d6) δ: 9.89 (s, 1H, NH), 8.58 (s, 1H, Ar-H), 8.38 (d, 1H, J = 8.1 Hz,
Ar-H), 8.18 (d, 1H, J = 8.1, Ar-H), 7.91-7.20 (m, 4H, Ar-H), 4.93 (2H, s, N-CH2), 4.30 (2H,s,
NH2), 4.11 (2H, s, CH2). 13C-NMR (50 MHz, DMSO-d6) δ: 168.1 (C=O), 160.2 (C=N), 151.3
(C), 147.3 (C), 145.7 (C), 140.2 (C), 137.9, 133.1 (CH), 129.6 (CH), 125.4 (CH), 122.8 (CH),
121.1 (CH), 120.4 (CH), 117.3 (CH), 48.2 (CH2), 36.0 (CH2). ESI-MS m/z (rel. int.) 362 [M+3]
(35), 360 [M+1] (100), 325 (50), 295 (9) 293 (29), 177 (32). Anal. C 53.42%, H 3.92%, N
19.47 %%, calcd. for C16H14ClN5O3, C 53.41%, H 3.93%, N 19.45 %.
2-[2-(3-Chlorobenzyl)-5(6)-nitro-1H-benzimidazol-1-yl]acetohydrazide (4d). m.p.: 250-251 °C,
IR (KBr): 3300 (NH, NH2), 3009 (Ar-H), 1655 (C=O), 1610 (C=N), 1511, 1313 (NO2) cm-1. 1H-
NMR (200 MHz, DMSO-d6) δ: 9.81 (s, 1H, NH), 8.60 (s, 1H, Ar-H), 8.28 (d, 1H, J = 8.0 Hz,
Ar-H,), 8.18 (d, 1H, J = 8.0, Ar-H), 7.71-7.10 (m, 4H, Ar-H), 4.96 (2H, s, N-CH2), 4.41 (2H,s,
NH2), 4.23 (2H, s, CH2). 13C-NMR (50 MHz, DMSO-d6) δ: 170.6 (C=O), 161.3 (C=N), 151.9
(C), 148.9 (C), 146.0 (C), 143.2 (C), 138.9, 135.9 (CH), 132.6 (CH), 128.4 (CH), 125.0 (CH),
121.8 (CH), 120.0 (CH), 115.9 (CH), 51.3 (CH2), 37.4 (CH2). ESI-MS m/z (rel. int.) 362 [M+3]
(35), 360 [M+1] (100), 325 (41), 295 (13) 293 (20), 177 (52). Anal. C 53.42%, H 3.92%, N
19.47 %%, calcd. for C16H14ClN5O3, C 53.44%, H 3.90%, N 19.49 %.
ACKNOWLEDGEMENT
This study was funded by the Scientific and Technological Research Council of Turkey
(TUBITAK, project no: 108T356).
REFERENCES
1. Sierra-Zenteno, A.; Galán-Vidal, C.; Tapia-Benavides, R. J. Mex. Chem. Soc. 2002, 46, 125.
2. Küçükbay, H.; Yılmaz, Ü.; Şireci, N.; Önganer, A.N. Turk. J. Chem. 2011, 35, 561.
Bull. Chem. Soc. Ethiop. 2013, 27(2)